Working… Menu
Trial record 1 of 1 for:    NCT02048865
Previous Study | Return to List | Next Study

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (AVERT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02048865
Recruitment Status : Completed
First Posted : January 29, 2014
Last Update Posted : November 20, 2018
Canadian Institutes of Health Research (CIHR)
Bristol-Myers Squibb
Information provided by (Responsible Party):
Ottawa Hospital Research Institute